Bora Pharmaceuticals Q4 2025 Financial Report
NQ Score
65/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Bora Pharmaceuticals reported a basic EPS of NT3.90, revenue of NT9.014 billion, and net income after tax of NT.046 billion for Q4 2025.
AI analysis data is not yet available.